01—History
R&D Expense History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $3.13B
1 older move runs past ±150% (largest +176.2%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is Moderna, Inc.'s current r&d expense?
Moderna, Inc. (MRNA) annual r&d expense for 2025 was $3.13B, a 31.06% decline from 2024. Moderna, Inc. r&d expense for the quarter ending March 31, 2026 was $649.0M.
What was Moderna, Inc.'s r&d expense in 2024?
Moderna, Inc. annual r&d expense for 2024 was $4.54B, a 6.23% decline from 2023.
What was Moderna, Inc.'s r&d expense in 2023?
Moderna, Inc. annual r&d expense for 2023 was $4.84B, a 47.04% increase from 2022.
What is Moderna, Inc.'s 5-year r&d expense CAGR?
Moderna, Inc. r&d expense grew at a compound annual growth rate (CAGR) of 17.98% from FY2020 to FY2025, going from $1.37B to $3.13B over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)